Price
Target price
€1.49
€1.49
2.570%
0.038
2.570%
€17.97
03.07.25 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
Iovance Biotherapeutics Inc. gained 2.570% today.
We see a rather positive sentiment for Iovance Biotherapeutics Inc. with 15 Buy predictions and 1 Sell predictions.
Based on the current price of 1.49 € the target price of 17 € shows a potential of 1038.04% for Iovance Biotherapeutics Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Iovance Biotherapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 2.570% | 0.769% | -6.439% | -78.006% | -78.370% | -85.817% | -94.227% |
| Ironwood Pharmaceuticals | 5.080% | -1.587% | 15.888% | -89.217% | -85.238% | -94.335% | -93.073% |
| Arrowhead Pharmaceuticals Inc. | 0.070% | 3.934% | -2.328% | -38.672% | -22.871% | -57.532% | -63.376% |
| Novocure Ltd | -0.400% | 3.354% | 0.700% | -3.422% | -48.146% | -78.511% | -72.006% |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $8.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Mizuho from $30.00 to $10.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Barclays PLC from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
